| Heading: |
Alzheimer's Disease: Medical Treatments |
| Question ID: |
1727962 |
| UIN: |
HL882 |
| House: |
Lords |
| Date tabled: |
2024-09-09 |
| Asking Member ID: |
3575 |
| Asking Member display name: |
Baroness Goudie
|
| Asking Member handle: |
BaronessGoudie
|
| Asking Member Twitter reference: |
@BaronessGoudie
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what discussions they have had with (1) the NHS, (2) NICE, and (3) MHRA, to ensure that NHS patients can access licensed treatments for Alzheimer's disease. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-09-23 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Department officials have had a number of conversations with colleagues in NHS England, the National Institute for Health and Care Excellence (NICE), and the Medicines and Healthcare products Regulatory Agency to discuss the progress of key regulatory dec... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |